AMANDA HOFFMAN: Open Payments
NPI 1982325155 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,808 in 77 payments from 19 companies in 2025. Trend: 2023 $2,771 · 2024 $1,336 · 2025 $1,808
Food & beverage: $1,808
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $313 |
| Sumitomo Pharma America, Inc. | 7 | $192 |
| PFIZER INC. | 11 | $186 |
| 180 Medical, Inc. | 7 | $184 |
| Endo USA, Inc. | 6 | $170 |
| UROGEN PHARMA, INC. | 6 | $149 |
| ABBVIE INC. | 7 | $131 |
| IMMUNITYBIO, INC. | 5 | $113 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $58 |
| TOLMAR, INC. | 3 | $54 |
Products named: XTANDI, RYBREVANT, ERLEADA, GEMTESA, ANKTIVA, AVEED, JELMYTO, BOTOX.
Industry payments across KY — which companies pay providers there.
